LBRX
LBRX
NASDAQ · Pharmaceuticals

Lb Pharmaceuticals Inc

$30.92
+0.32 (+1.05%)
As of Jun 24, 2:40 PM ET ·
Analyst Consensus
Strong Buy
12
Analysts
Moderate
Coverage
Buy 11 92%
Hold 1 8%
Sell 0 0%
Price Target
Analyst Price Target -50.8% upside
Low Target $11.61
Average Target $15.21
High Target $18.52
Current Price $30.92
Current
$30.92
Target
$15.21
$11.61 $15.21 avg $18.52
Scenario Analysis
Bear Case
$11.61
-62.5%
Low target
Base Case
$15.21
-50.8%
Avg target
Bull Case
$18.52
+-40.1%
High target
Risk/Reward
0.6x
Unfavorable
Price in Context
52-Week High
$33.47
-7.6% from high
52-Week Low
$13.36
+131.4% from low
Target vs 52W High
$15.21
-54.6% vs high
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
LLY
Eli Lilly and Co.
Strong Buy 39 79% $1,330.33 +19.1%
RDY
Dr. Reddy's Laboratories
Sell 44 50% +0.0%
JNJ
Johnson & Johnson
Buy 31 68% $299.55 +24.3%
MRK
Merck & Co. Inc.
Buy 36 69% $159.27 +32.1%
PFE
Pfizer Inc.
Hold 36 42% $33.90 +41.0%
BMY
Bristol-Myers Squibb Co
Hold 36 39% $174.50 +217.3%
ZTS
Zoetis Inc
Buy 24 58% $209.87 +168.5%
RPRX
Royalty Pharma Plc- Cl A
Strong Buy 16 88% $36.26 -33.2%